Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
Signs Agreement
|
Strong Performer, Getting Expensive
2095.0000
3.00
(
0.14
%)
NSE
Dec 05, 2025
09:07 AM
Volume:
679
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
09 Feb 2024
Signs Agreement
2095.00
0.14%
Lupin (HOLD): All-round beat; margins sustain raise to HOLD
Hold:
Lupin Ltd.
by
BOB Capital Markets Ltd.
Target: 1560
Recommendation
Target
BOB Capital Markets Ltd.
Strong Q3 with EBITDA/PAT of Rs 10.2bn/Rs 6.1bn, beating consensus by 17%/42%
Lupin Ltd. is trading above all available SMAs
More from Lupin Ltd.
Recommended
Market closes higher, supported by gains in IT and telco stocks
Trendlyne Marketwatch |
04 Dec 2025, 03:59PM
Could Rs 90 per dollar be good for India?
The Baseline |
03 Dec 2025, 12:23PM
Lupin expects normalization by September quarter
|
17 Apr 2020